Hexa Health Benefits
Trusted Doctors and Top Hospitals
Consultations with expert surgeons
Extensive assistance throughout your treatment
Table of Contents
Book Consultation
A rare genetic disorder, Crigler-Najjar syndrome impacts the liver’s ability to process bilirubin. It affects about 0.6 to 1 in one million newborns around the world. The condition can cause life-threatening symptoms and irreversible brain damage if left untreated.
People usually confuse Crigler-Najjar syndrome with Gilbert syndrome. The following blog compares Gilbert syndrome vs Crigler-Najjar syndrome. Furthermore, it discusses the types, symptoms, and causes of Crigler-Najjar syndrome. Continue reading to find out.
Disease Name | Crigler-Najjar Syndrome |
Symptoms | Muscle spasms, Hearing loss, Fatigue, Trouble with sensory perception |
Causes | Genetic mutation, Family history |
Diagnosis | Bilirubin Blood Test, Blood and stool test, Genetic testing, Liver biopsy |
Treated by | Hepatologist and Gastro-intestinal Surgeon |
Treatment Options | Phototherapy, Plasmapheresis, Liver transplantation |
Crigler-Najjar syndrome is a rare genetic disorder that affects the liver’s ability to process bilirubin. Bilirubin is a yellow pigment which is produced when red blood cells break down.
The liver converts bilirubin from a toxic substance (unconjugated bilirubin) to a nontoxic substance (conjugated bilirubin). People get rid of the nontoxic bilirubin in their stool.
The liver cannot break down toxic bilirubin in people with Crigler-Najjar syndrome. As a result, they have a buildup of toxic bilirubin in their blood.
Crigler-Najjar syndrome is typically categorised into two main types. The classification is based on the severity of the syndrome. These two types include:
Type 1 (CN1): Crigler-Najjar syndrome type 1 is a very severe form of the disease. The condition is life-threatening.
Most children die in childhood due to disease complications, such as kernicterus (brain damage caused by jaundice).
Type 2 (CN2): Crigler-Najjar syndrome type 2 is less severe than CN1. Children diagnosed with type 2 are less likely to develop kernicterus.
Most children with this type have a normal life expectancy and survive into adulthood.
Crigler-Najjar syndrome symptoms differ in severity based on the type. The symptoms of CN1 become apparent shortly after the birth of the child.
Newborns with Crigler-Najjar syndrome develop severe jaundice (yellowing of the skin and eyes).
It is common for infants to have jaundice, which generally resolves during the first week. However, children with this syndrome experience jaundice that persists beyond the first three weeks of life.
Infants risk developing kernicterus, called bilirubin encephalopathy, within the first month or early childhood. Kernicterus is a type of brain damage that results from high bilirubin levels in the baby’s blood.
Mild symptoms of kernicterus may include the following neurological or movement problems:
Clumsiness (poor coordination, movement, or action)
Muscle spasms (painful contractions and tightening of the muscles)
Difficulty with fine motor skills (playing with fingers, grasping objects, etc.)
The trouble with sensory perception (the brain has trouble processing information from the senses)
Choreoathetosis (involuntary twisting movements of the body)
Severe symptoms of kernicterus include:
Hearing loss
Extreme fatigue or lack of energy (lethargy)
Severe muscle spasms, causing arching of the back
Nausea or vomiting
Fever
Difficulty with feeding
Problems with cognitive development
Hypertonia (episodes of increased muscle tone) or hypotonia (weak muscle tone)
Expert Doctors (10)
NABH Accredited Hospitals (10)
Crigler-Najjar syndrome causes include mutations in the UGT1A1 gene. This genetic mutation affects the production or function of the bilirubin uridine diphosphate glucuronosyltransferase (bilirubin-UGT) enzyme.
Crigler-Najjar syndrome pathophysiology is as follows:
The bilirubin-UGT enzyme, primarily found in the liver cells, transfers glucuronic acid to unconjugated (toxic) bilirubin, converting it to conjugated (nontoxic) bilirubin.
This process makes bilirubin soluble and easier to excrete from the body.
The specific genetic mutations associated with Crigler-Najjar Syndrome disrupt the normal activity of the bilirubin-UGT enzyme, leading to impaired bilirubin processing.
Individuals with type 1 of the syndrome have no enzyme function, whereas individuals with type 2 have less than 20% of normal enzyme function.
The loss of enzyme function prevents the body from converting bilirubin into its nontoxic form, causing a toxic substance buildup in the blood.
The primary risk factor for Crigler-Najjar syndrome is having a family history of the condition. It is an inherited genetic disorder passed down from parents to their children.
Crigler-Najjar syndrome inheritance follows an autosomal recessive pattern, i.e., both parents must carry a copy of the UGT1A1 mutated gene for their child to be affected.
If only one parent passes the mutated gene to the child, the mutation may cause a less severe condition called Gilbert syndrome.
The number of inherited UGT1A1 mutated genes is the primary difference between Gilbert syndrome vs Crigler-Najjar syndrome.
Currently, there is no known way to prevent the development of Crigler-Najjar syndrome, as it is a genetic disorder caused by specific gene mutations.
However, some steps can help reduce the risk of passing these gene mutations to future generations. These measures include:
Regular Monitoring: Individuals with Crigler-Najjar syndrome require ongoing monitoring of their bilirubin levels.
Blood tests can help assess the concentration of toxic bilirubin in the bloodstream.
Genetic Counselling: People who have a family history of Crigler-Najjar syndrome should consider genetic counselling before planning to become pregnant.
Genetic counsellors can help couples understand the risk of passing the condition to their children. They may also provide information about family planning options.
Severe jaundice within the first few days to weeks of birth may result in suspicion of the syndrome. The healthcare provider will conduct a physical exam and evaluate the individual’s medical history.
The healthcare provider may recommend some tests to confirm the Crigler-Najjar syndrome diagnosis. These diagnostic tests include:
Bilirubin Blood Tests: The doctor may perform blood tests to detect the total bilirubin level in the patient’s blood.
Blood and Stool Tests: Tests like liver function tests or a complete blood count help determine the level of unconjugated bilirubin in the patient’s blood and stool.
In type 1 of the syndrome, the unconjugated bilirubin level is between 20 and 25 mg/dL and 50 mg/dL for severe cases. In type 2, the level is generally less than 20 mg/dL.
Genetic Testing: It can confirm the diagnosis of Crigler-Najjar syndrome and identify specific mutations in the UGT1A1 gene.
Genetic testing involves analysing a sample of the individual’s DNA, usually obtained through a blood sample or cheek swab.
Liver Biopsy: Sometimes, doctors may perform a liver biopsy to evaluate or rule out other liver diseases like liver cirrhosis.
Preparing for a doctor’s consultation for Crigler-Najjar syndrome can help individuals make the most of their appointment and address their concerns effectively. Here are some tips to help them prepare:
Note Down Symptoms: Patients must note down the symptoms they experience and their duration.
Make a List of Medications: Enlisting the medication, supplements, and herbs the patient takes is recommended.
This helps the doctor understand if there are any drug interactions.
Know the Family History: Crigler-Najjar syndrome is a genetic condition.
So patients must be prepared to provide detailed information about the family history of the disorder.
Write Questions for the Doctor: Noting questions beforehand will ensure that the patient covers all the important topics during the appointment.
This helps them receive the necessary information.
Bring a Friend or Family Member: Patients should consider taking a friend or family member to the appointment.
They can offer support and help remember important information.
During a Crigler-Najjar syndrome appointment, the doctor may ask several questions to gather relevant information about the patient’s health and medical history.
Here are some questions that the doctor may ask:
When did you or your child first notice the onset of jaundice?
Do you experience any other symptoms of jaundice, such as fatigue, weakness, or neurological symptoms?
Does anything seem to improve or worsen jaundice or affect overall health?
Do you have a family history of Crigler-Najjar syndrome?
How frequently are your bilirubin levels monitored, and what are the typical levels?
Have you considered or undergone genetic testing or counselling?
Asking questions during a Crigler-Najjar syndrome appointment can help better understand the condition, treatment options, and management strategies.
Here are some questions individuals may consider asking the doctor:
What type of Crigler-Najjar syndrome does my child have?
How often should bilirubin levels be monitored, and what level is considered safe?
What are the available treatment options, and which one do you recommend?
What is the goal of treatment for Crigler-Najjar syndrome?
Are there any side effects of these treatments?
How long will my child need phototherapy?
Does my child need a liver transplant?
Are there any potential complications associated with the disease that I should be aware of?
Are there any lifestyle modifications or dietary recommendations to help manage the condition?
Should I consider genetic counselling for myself or my family members?
The main goal of treatment for Crigler-Najjar syndrome is the reduction of bilirubin levels in the body. The treatment options for type 1 and type 2 of the syndrome may differ.
Treatment could include:
Phototherapy: The primary Crigler-Najjar syndrome type 1 treatment is phototherapy.
In this procedure, the skin is exposed to bright lights to remove bilirubin from the body.
The light moves bilirubin through the body into the bile and intestines for elimination without converting it into its conjugated form.
The treatment is less effective in older children and adults due to increased skin pigmentation and thicker skin.
Plasmapheresis: It is the most effective treatment for removing excess unconjugated bilirubin from the blood.
In this procedure, the patient’s blood is removed, and blood cells are separated from plasma.
The plasma is replaced with healthy plasma, usually from a donor, and the blood is transferred to the patient.
Medicines: The doctor may prescribe medications to treat infections or illnesses resulting in fever.
Liver transplantation: This is the only definitive treatment for type 1 of the syndrome.
It is a surgical procedure in which the patient’s liver is removed and replaced with a healthy donor liver.
Phenobarbital: Therapy with phenobarbital prevents bilirubin buildup in the blood. It effectively treats Crigler-Najjar syndrome type 2, reducing the serum bilirubin level by 25%.
Please Note: The selection of the treatment approach is based on the patient’s disease type and condition and the treating doctor’s opinion.
The cost of the Crigler-Najjar syndrome treatment in India varies on several factors, including the patient’s age, other comorbidities, type of the condition, doctor’s expertise, type and location of the hospital and much more.
To know the exact cost of the Crigler-Najjar syndrome treatment in India, one must consult their doctor.
However, the below table also provides the approximate cost of the treatment modalities for the Crigler-Najjar syndrome.
Treatment Options | Cost Estimated Range |
Phototherapy (per session) | ₹ 15,000 to ₹ 25,000 |
Plasmapheresis (per session) | ₹ 15,000 to ₹ 25,000 |
Liver Transplant | ₹ 15,00,000 to ₹ 35,00,000 |
Crigler-Najjar syndrome prognosis can vary depending on several factors. These factors include the type, the severity of the condition, and the individual’s response to treatment.
The prognosis for the types of syndrome is as follows:
Infants with a mild form of the disease (type 2) experience fewer symptoms and less organ damage.
Individuals with type 2 syndrome will have a good prognosis with early treatment.
Infants with a severe form of the disease (type 1) will have a poor diagnosis if the condition is not diagnosed and treated within the first few months of birth.
Children have a risk of developing life-threatening symptoms, preventing them from living more than two years.
Most individuals with this syndrome require lifetime treatment. With effective treatment and management, people can have a normal life expectancy.
The Crigler-Najjar syndrome can lead to various complications. It is especially true if the condition is not properly managed or if bilirubin levels remain elevated over an extended period.
Here are some potential complications associated with Crigler-Najjar syndrome:
Kernicterus: It refers to the deposition of unconjugated bilirubin in the brain, leading to neurological damage. Severe and prolonged elevation of bilirubin levels, probably above 25 mg/dL, increases the risk of kernicterus.
It is more commonly seen in type 1 of Crigler-Najjar syndrome, but patients with type 2 can also develop this complication.Chronic Jaundice: Individuals can develop chronic jaundice when the syndrome is persistent, and the diagnosis is delayed. The limited bilirubin excretion causes the serum level to increase progressively.
Cholelithiasis: Increased levels of unconjugated bilirubin can cause gallstone formation later in life.
Liver Cirrhosis: This is not a direct complication of Crigler-Najjar syndrome. A baby born with this syndrome has a healthy liver in most cases.
The exact mechanisms by which liver cirrhosis occurs are not fully understood. However, it may develop due to:
Chronic biliary obstruction after cholelithiasis
Toxicity from drugs metabolised in the liver
Toxicity from phototherapy
It is important to consult a healthcare professional if an individual or their child exhibits symptoms or signs of Crigler-Najjar syndrome, such as persistent jaundice.
Some additional symptoms that may require seeking medical attention include:
High fever
Persistent jaundice after phototherapy
Developmental delays
Difficulty eating
While no specific diet can cure Crigler-Najjar syndrome, certain considerations may be helpful.
Patients must consult with a healthcare provider or registered dietitian to receive personalised advice based on their needs.
Here are some general dietary recommendations:
High-Carbohydrate Foods: People with Crigler-Najjar syndrome cannot process fats and proteins.
Therefore, they should eat more carbs to compensate for fats and proteins.
Sources of carbohydrates include vegetables, fruits, legumes, and whole grains.
Nutrient-Rich Foods: Foods high in nutrients can help improve general health and prevent deficits.
Examples include fruits, vegetables, nuts, seeds, whole grains, and lean protein sources.
Fluids: Drinking lots of fluids, especially water, can help avoid dehydration and promote good liver function.
High-Fat Foods: Individuals with Crigler-Najjar syndrome may have trouble digesting high-fat foods.
Processed meats or fried foods can affect liver function and worsen the symptoms.
Sugar: Consuming excessive sugar (in the form of sugary drinks or refined sugar) can cause individuals to experience liver issues. Therefore, high intake of sugar must be avoided.
Alcohol: Regular and high consumption of alcohol can cause liver damage and worsening symptoms.
Crigler-Najjar syndrome is a rare genetic disorder characterised by impaired bilirubin metabolism, resulting in elevated bilirubin levels. It can lead to jaundice and requires lifelong management.
Differentiating Gilbert syndrome vs Crigler-Najjar syndrome is important for accurate diagnosis and appropriate treatment.
If you or a loved one is affected by Crigler-Najjar syndrome, the HexaHealth team can provide valuable support. Our expert healthcare professionals can offer comprehensive guidance, personalised treatment plans, and ongoing monitoring.
Furthermore, we can connect you with relevant resources to enhance your quality of life. Contact us TODAY!
Suggested Reads
Crigler-Najjar syndrome is a rare genetic disorder characterised by the absence or deficiency of an enzyme called UDP-glucuronosyltransferase. This leads to impaired bilirubin processing.
A lack of enzyme function results in elevated bilirubin levels in the blood, resulting in jaundice and other neurological complications.
Gilbert syndrome vs Crigler-Najjar syndrome can be compared according to the severity of these conditions.
Gilbert Syndrome is a benign and mild condition characterised by elevated bilirubin levels, often triggered by tiredness, intercurrent illness, or fasting. Only one parent passes the mutated gene to the child in this condition.
Crigler-Najjar syndrome is a more severe genetic disorder with complete or partial deficiency of bilirubin-conjugating enzyme, leading to higher bilirubin levels.
In this condition, both parents pass the mutated gene to the child.
Crigler-Najjar syndrome is classified into two types:
CN1 is the more severe form with near-complete deficiency of bilirubin-UGT enzyme.
CN2 is a milder form with partial bilirubin-UGT deficiency.
Crigler-Najjar syndrome type 1 (CN1) is the more severe form of the condition. It is characterised by an almost complete absence of the enzyme UGT activity. Individuals affected can die in childhood due to brain damage.
Crigler-Najjar syndrome type 2 (CN2) is milder than type 1. A partial deficiency of the enzyme UGT activity characterises it. Individuals affected with type 2 are less likely to develop brain damage. Most individuals survive into adulthood.
Crigler-Najjar syndrome is a rare genetic disorder that can affect individuals of any gender or ethnic background.
Children inherit the condition from their parents during conception if both parents pass a copy of the UGT1A1 mutated gene.
The primary symptom of Crigler-Najjar syndrome is jaundice (the yellowing of the skin and eyes). Other potential symptoms include:
Fever
Extreme fatigue
Difficulty feeding
Muscle spasms
Hearing difficulties
Involuntary twisting movements of the body
Crigler-Najjar syndrome inheritance follows an autosomal recessive pattern. This means both parents must carry a mutated gene for the condition to be passed on to their child.
Crigler-Najjar syndrome pathophysiology involves a deficiency or absence of the enzyme bilirubin-UGT. This enzyme is responsible for converting toxic bilirubin into its nontoxic form.
The deficiency of this enzyme results in elevated levels of unconjugated (toxic) bilirubin in the blood, leading to jaundice and potential complications.
Crigler-Najjar syndrome causes genetic mutations in the UGT1A1 gene, which produces the UGT enzyme.
These mutations lead to reduced or absent UGT activity. This results in impaired bilirubin metabolism and the development of the syndrome.
Crigler-Najjar syndrome diagnosis begins with a physical exam and evaluation of the individual’s medical history. The doctor may order several tests for diagnosis, such as:
Bilirubin blood tests: to detect the total bilirubin level in an individual’s blood
Blood and stool tests: to determine the level of unconjugated bilirubin in an individual’s blood and stool
Genetic testing: to confirm the diagnosis and identify specific mutations in the UGT1A1 gene
Liver biopsy: to evaluate or rule out other liver diseases
Yes, there is a cure for Crigler-Najjar syndrome. A liver transplant is the only cure for the disease. Replacing the patient’s damaged liver with a healthy donor liver helps break down bilirubin.
This prevents the occurrence of life-threatening symptoms like brain damage.
There are several treatment options for Crigler-Najjar syndrome. These include:
Phototherapy: The skin is exposed to bright lights to remove bilirubin from the body
Plasmapheresis: It removes excess unconjugated bilirubin from the blood through blood transfusion
Medicines: It treats infections or illnesses resulting in fever
Liver transplantation: A surgical procedure in which the patient’s liver is removed and replaced with a healthy donor liver
Phenobarbital: It prevents bilirubin buildup in the blood
Phototherapy is the first-line Crigler-Najjar syndrome type 1 treatment. It involves regular exposure to specialised lights to break down bilirubin.
In severe cases or when phototherapy is ineffective, liver transplantation is a potential treatment option.
A liver transplant is the only potential cure for type 1 of Crigler-Najjar syndrome. It is a surgical procedure that replaces the patient’s liver with a healthy donor’s liver. The healthy liver breaks down bilirubin, preventing life-threatening complications.
There is ongoing research to design therapies that replace the absent or deficient enzyme. Gene therapy clinical trials are currently underway.
In gene therapy, an abnormal UTG1A1 gene is replaced with a normal UTG1A1 gene to help the body make functional UGT enzymes.
Preventive measures for Crigler-Najjar syndrome primarily involve regular monitoring to manage bilirubin levels and prevent complications. Couples with the syndrome who plan to have a child must undergo genetic counselling.
It helps to understand the risk of passing the syndrome to their child.
Yes, prenatal diagnosis can help detect Crigler-Najjar syndrome. However, for prenatal detection, both disease-causing mutations must have been identified.
Crigler-Najjar syndrome affects bilirubin metabolism by causing a deficiency or absence of the UDP-glucuronosyltransferase (UGT) enzyme. The enzyme is responsible for converting unconjugated bilirubin into conjugated bilirubin.
The deficiency impairs bilirubin metabolism, leading to high unconjugated bilirubin levels in the blood.
There are no specific dietary considerations to cure Crigler-Najjar syndrome.
Eating foods rich in carbohydrates and nutrients is typically recommended to support overall well-being and liver health.
Individuals with this syndrome should avoid consuming high-fat foods, excessive sugar, and alcohol.
The long-term complications of Crigler-Najjar syndrome primarily involve the potential neurological damage caused by increased bilirubin levels. This can cause:
Cognitive delays
Kernicterus (brain damage from high bilirubin levels) in severe cases
Yes, liver transplantation can be a potential treatment option for individuals with severe Crigler-Najjar syndrome.
It is particularly useful in cases where phototherapy is ineffective or not feasible.
The life expectancy for individuals with Crigler-Najjar Syndrome type 1 can vary. With appropriate management and regular treatment, the life expectancy for someone with CN1 is 30 years.
Another name for Crigler-Najjar syndrome is Arias syndrome. It is a milder form characterised by partial deficiency of UGT enzyme activity.
Crigler-Najjar type 2 is comparatively benign, usually observed in infants or early childhood. It is less severe than type 1.
However, type 2 can still cause complications and requires regular monitoring and management.
Gilbert’s syndrome is a mild, benign disorder of bilirubin metabolism within the liver. It causes intermittent elevation of unconjugated bilirubin levels in the blood.
Dubin-Johnson syndrome is a rare, benign liver disorder causing a buildup of conjugated bilirubin. This happens due to impaired bilirubin excretion.
The prognosis of type 2 of Crigler-Najjar syndrome is generally favourable. With proper management, individuals with CN2 can have relatively normal lives with a decreased risk of severe complications.
Children diagnosed with this type have a normal life expectancy due to mild symptoms.
In Gilbert’s syndrome, there is a mild deficiency in the UGT enzyme, which is responsible for the conjugation of bilirubin.
This leads to elevated levels of unconjugated bilirubin in the blood.
A deficiency of vitamin B12 can sometimes lead to high bilirubin levels. The deficiency of this vitamin leads to jaundice, making an individual’s skin and eyes take on a yellowish colour.
Crigler-Najjar syndrome cannot be prevented as it is a genetic disorder. However, individuals can reduce the risk of passing it to future generations through regular monitoring and genetic counselling.
When taking care of a child with Crigler-Najjar syndrome, it is important to follow the prescribed treatment plan, which may include regular phototherapy sessions.
In phototherapy, the child is exposed to blue LED lights, even during sleep.
Therefore, parents must comfort their children during treatments by talking to them until they adjust and sleep.
It is also important to ensure proper hydration of their children during treatment.
Individuals with Crigler-Najjar syndrome can expect a lifelong need for treatment and management to control bilirubin levels.
Treatment may involve regular phototherapy sessions and close monitoring of bilirubin levels.
CN2 generally has a good prognosis with appropriate treatment.
CN1 has a poorer prognosis if the condition is not diagnosed and treated within the first few months of birth.
Myth: Crigler-Najjar syndrome is a common condition.
Fact: Crigler-Najjar syndrome is an extremely rare genetic disorder. It is estimated to affect only 1 in every 1 million people worldwide.Myth: Crigler-Najjar syndrome can be cured.
Fact: Currently, there is no cure for Crigler-Najjar syndrome. However, there are treatment options available to manage the symptoms and complications associated with the condition.Myth: Crigler-Najjar syndrome is contagious.
Fact: Crigler-Najjar syndrome is not contagious. It is an inherited genetic disorder that is passed down from parents to their children.All the articles on HexaHealth are supported by verified medically-recognized sources such as; peer-reviewed academic research papers, research institutions, and medical journals. Our medical reviewers also check references of the articles to prioritize accuracy and relevance. Refer to our detailed editorial policy for more information.
Last Updated on: 17 July 2023
MBBS, DNB General Surgery, Fellowship in Minimal Access Surgery, FIAGES
12 Years Experience
Dr Aman Priya Khanna is a well-known General Surgeon, Proctologist and Bariatric Surgeon currently associated with HealthFort Clinic, Health First Multispecialty Clinic in Delhi. He has 12 years of experience in General Surgery and worke...View More
She has extensive experience in content and regulatory writing with reputed organisations like Sun Pharmaceuticals and Innodata. Skilled in SEO and passionate about creating informative and engaging medical conten...View More
Book Consultation
Latest Health Articles